An official website of the United States government
NIH Guide: Weekly Index for November 10, 2023
Weekly NIH Funding Opportunities and Notices
November 10, 2023
General Notices
-
Notice of NCCIH Technical Assistance Webinar for PAR-23-256 "Feasibility Trials of the NIH Music-based Interventions (MBIs) Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)"
(NOT-AT-24-024)National Center for Complementary and Integrative HealthNational Institute on Aging
-
Notice of NCCIH Technical Assistance Webinar for RFA-AT-24-006 "Resource Center for Cannabis and Cannabinoid Research (U24 Clinical Trial Not Allowed)"
(NOT-AT-24-025)National Center for Complementary and Integrative Health
-
Notice of Technical Assistance Webinar and FAQs for RFA-HD-24-007 (Understanding and Mitigating Health Disparities experienced by People with Disabilities caused by Ableism (R01 Clinical Trial Optional))
(NOT-HD-23-034)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Closing February 1, 2024 Application Receipt Date for RFA-OH-23-005 NIOSH Robotics and Intelligent Mining Technology and Workplace Safety Research (U60)
(NOT-OH-24-002)National Institute for Occupational Safety and Health
-
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional): Notice of Technical Webinar
(NOT-TR-24-002)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
-
Notice of Request for Information (RFI) to Facilitate Cancer Systems immunology Research
(NOT-CA-24-003)National Cancer Institute
Notice of Changes to Funding Opportunities
-
Notice of Change to Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed), PAR-23-033
(NOT-AI-24-004)National Institute of Allergy and Infectious Diseases
-
Notice of Change to Award Budget for PAR-23-032, Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed
(NOT-AR-23-021)National Institute of Arthritis and Musculoskeletal and Skin Diseases
-
Notice of Change to Letter of Intent Due Date for RFA-DK-23-004: Human Islet Research Network - Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD) (UG3/UH3 Clinical Trial Not Allowed)
(NOT-DK-24-002)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Extension of the First Receipt Date of RFA-HG-23-018: Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial (Clinical Trial Optional)
(NOT-HG-24-008)National Human Genome Research Institute
-
Notice of NINRs Scientific Interests for PAR-23-137, NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
(NOT-NR-24-002)National Institute of Nursing Research
-
Notice of Termination of PAR-21-340 "Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trial Not Allowed)
(NOT-TR-24-001)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Model Continuums of Care Initiative (MCCI) to Advance Health Equity Among Women and Girls in Racial/Ethnic Minority and Other Marginalized Communities (U34 Clinical Trials Required)
(NOT-AA-24-002)National Institute on Alcohol Abuse and Alcoholism
-
Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
(NOT-NS-24-017)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and Bioengineering
Notices of Special Interest
-
Notice of Special Interest (NOSI): Development of Organotypic Culture Models for Transplantation Immunology Research
(NOT-AI-23-064)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): National Cancer Institute Entrepreneurial Education Programs to Facilitate Commercialization of Cancer Relevant Technologies
(NOT-CA-24-001)National Cancer Institute
-
Notice of Special Interest (NOSI): Interventions to promote mental well-being in populations that experience health disparities through social, cultural, and environmental connectedness
(NOT-OD-23-194)Office of Disease PreventionNational Institute on AgingNational Institute of Dental and Craniofacial ResearchNational Institute of Mental HealthNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Research on Women's HealthOffice of AIDS ResearchNational Institute on Minority Health and Health Disparities
Funding Opportunities
-
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
(PAR-23-286)National Cancer InstituteApplication Receipt Date(s): October 14, 2026
-
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
(PAR-23-287)National Cancer InstituteApplication Receipt Date(s): October 14, 2026
-
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
(PAR-23-288)National Cancer InstituteApplication Receipt Date(s): October 14, 2026
-
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
(PAR-24-035)National Institute of Arthritis and Musculoskeletal and Skin DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
(PAR-24-036)National Institute of Arthritis and Musculoskeletal and Skin DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)
(PAR-24-053)Office of Disease PreventionNational Institute on Alcohol Abuse and AlcoholismNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Heart, Lung, and Blood InstituteNational Institute of Nursing ResearchNational Center for Complementary and Integrative HealthOffice of Research on Women's HealthOffice of Dietary SupplementsNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): August 05, 2024
-
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
(PAR-24-054)National Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesApplication Receipt Date(s): December 9, 2024
-
Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)
(PAR-24-062)National Institute on Drug AbuseNational Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): Multiple dates, see announcement.
-
Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only)
(RFA-DA-24-036)National Institute on Drug AbuseOffice of Disease PreventionApplication Receipt Date(s): January 26, 2024
-
The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
(RFA-DA-25-027)National Institute on Drug AbuseApplication Receipt Date(s): March 13, 2024
-
National Drug Early Warning System Coordinating Center (U01 Clinical Trial Not Allowed)
(RFA-DA-25-029)National Institute on Drug AbuseApplication Receipt Date(s): March 20, 2024
-
In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
(RFA-DC-24-004)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): January 5, 2025
-
Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
(RFA-DC-24-005)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): January 5, 2025
-
Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
(RFA-HG-23-032)National Human Genome Research InstituteNational Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
(RFA-HG-23-033)National Human Genome Research InstituteNational Cancer InstituteApplication Receipt Date(s): November 18, 2024
-
Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
(RFA-HG-23-048)National Human Genome Research InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Coordinating Center to Support Multi-Sectoral Preventive Interventions that Address Social Determinants of Health in Populations that Experience Health Disparities (U24, Clinical Trial Not Allowed)
(RFA-OD-24-006)Office of Disease PreventionNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): August 5, 2024
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: January 15, 2025
For technical issues E-mail OER Webmaster